Chr. Hansen Overview

  • Founded
  • 1873
Founded
  • Status
  • Public
  • Employees
  • 3,286
Employees
  • Stock Symbol
  • CHR
Stock Symbol
  • Investments
  • 14
  • Share Price
  • $77.76
  • (As of Friday Closing)

Chr. Hansen General Information

Description

Founded in 1874 and relisted in 2010 after five years of private ownership, Chr. Hansen is a global bioscience company with more than 3,200 employees across 30 countries. Its segments include food cultures and enzymes that produce and sell innovative cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf-life, nutritional value, and health benefits of a variety of consumer products in the food industry, especially in the dairy industry; and health and nutrition that produce and sell products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Commercial Products
Other Industries
Other Business Products and Services
Other Consumer Non-Durables
Specialty Chemicals
Food Products
Stock Exchange
CSE
Primary Office
  • Boege Allé 10-12
  • 2970 Hoersholm
  • Denmark
+45 45 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chr. Hansen Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$77.76 $77.38 $76.48 - $109.78 $10.2B 131M 259K $7.67

Chr. Hansen Financials Summary

In Thousands,
USD
TTM 31-Aug-2021 FY 2021 31-Aug-2021 FY 2020 31-Aug-2020 FY 2019 31-Aug-2019
EV 13,293,448 13,293,448 16,103,576 11,954,144
Revenue 1,287,570 1,287,570 1,079,817 1,062,330
EBITDA 438,352 438,352 421,574 411,491
Net Income 1,010,074 1,010,074 272,737 283,545
Total Assets 3,673,575 3,673,575 3,400,908 2,275,849
Total Debt 1,124,533 1,124,533 1,694,614 908,880
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Chr. Hansen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chr. Hansen‘s full profile, request access.

Request a free trial

Chr. Hansen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Founded in 1874 and relisted in 2010 after five years of private ownership, Chr. Hansen is a global bioscience company w
Other Commercial Products
Hoersholm, Denmark
3,286 As of 2020
00000
00000000000 00000

00000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
0000 000000000
Mumbai, India
000 As of 0000
0000
000000000000 0000

0000000

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
00000 00000000 000-00000000
Avignon, France
0000 As of 0000
000.00
0.000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Chr. Hansen Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OmniActive Health Technologies Private Equity-Backed Mumbai, India 000 0000 000000000000 0000
0000000 Corporate Backed or Acquired Avignon, France 0000 000.00 000000&0 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Chr. Hansen Patents

Chr. Hansen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3866606-A1 Lactase enzymes with improved properties at acidic ph Pending 17-Oct-2018 0000000000000
US-20200109359-A1 Yeast for beer production Pending 04-Oct-2018 0000000000
EP-3840577-A1 Process for producing an improved fermented milk product using a sporulation negative bacillus strain Pending 21-Aug-2018 000000000
US-20210195907-A1 Process for producing an improved fermented milk product using a sporulation negative bacillus strain Pending 21-Aug-2018 000000000
AU-2019321847-A1 Production of alcohol-free fermented vegetable juice with pichia kluyveri yeast Pending 13-Aug-2018 A23L2/70

Chr. Hansen Executive Team (13)

Name Title Board Seat Contact Info
Mauricio Graber Executive Board Member, Chief Executive Officer & President
Lise Skaarup Mortensen Executive Vice President, Chief Financial Officer & Executive Board Member
Annika Stern Senior Investor Relations Officer
Torsten Steenholt Executive Vice President, Global Operations
Jan Kuhlmann Vice President, Animal Health & Nutrition
You’re viewing 5 of 13 executive team members. Get the full list »

Chr. Hansen Board Members (10)

Name Representing Role Since
000000000 00000000 Self Chair of the Board of Directors 000 0000
000000 0000000 Self Board Member 000 0000
00000000 000000000 Chr. Hansen Board Member & Member of the Audit Committee 000 0000
0000 000000000 Self Board Member 000 0000
0000 000000 Self Board Member & Chairman of the Audit Committee 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Chr. Hansen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chr. Hansen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Chr. Hansen‘s full profile, request access.

Request a free trial

Chr. Hansen Investments & Acquisitions (14)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 09-Oct-2020 000000000000000000 00000 Biotechnology 00000000 000000
000 000000000000 27-Jul-2020 000000000000000000 00000 Pharmaceuticals 00000000 000000
0000000 0000000000 20-Apr-2020 000000000000000000 00000 Biotechnology 00000000 000000
00000000 02-Sep-2019 00000 0000000 Therapeutic Devices 00000000 000000
LGG 10-Nov-2016 Merger/Acquisition 000.00 Biotechnology 0000 00 0000 00
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Chr. Hansen Subsidiaries (2)

Company Name Industry Location Founded
Astarte Probiotics Biotechnology Vienna, Austria 2007
000 000000000000 Pharmaceuticals Wausau, WI 0000
To view Chr. Hansen’s complete subsidiaries history, request access »

Chr. Hansen Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 000000000 0000 01-Feb-2008 0000000000 Completed
  • 2 buyers
To view Chr. Hansen’s complete exits history, request access »